National Pharmaceutical Industry
Mostrando 1-12 de 24 artigos, teses e dissertações.
-
1. Ethanol Content Determination in Medicine Syrups Using Headspace and Multidimensional Heart-Cut Gas Chromatography Coupled to Mass Spectrometry
Despite the efforts of the pharmaceutical industry to reduce the ethanol content in medicines, many of these products are still commercially available. These medicines must be monitored by quality control techniques using accurate method. Therefore, this study proposes to develop and validate an analytical method for ethanol quantification in adult and pedia
J. Braz. Chem. Soc.. Publicado em: 2020-02
-
2. ABORDAGEM DIDÁTICA PARA O DESENVOLVIMENTO DE MOLÉCULAS BIOATIVAS: REGRA DOS CINCO DE LIPINSKI E PREPARAÇÃO DE HETEROCICLO 1,3,4-OXADIAZOL EM FORNO DE MICRO-ONDAS DOMÉSTICO
In Brazil, the development of new chemical entities (NEQ) is still limited to small advances in the academic and public research sectors, the authors understand that this is a sector of the pharmaceutical industry that needs encouragement. Accepting that education transforms society, educate students in the development of bioactive molecules, it’s a way to
Quím. Nova. Publicado em: 2018-01
-
3. Pharmaceutical lobbying in Brazil: a missing topic in the public health research agenda
ABSTRACT In the US, where registration of lobbyists is mandatory, the pharmaceutical industry and private health-care providers spend huge amounts of money seeking to influence health policies and government decisions. In Brazil, where lobbying lacks transparency, there is virtually no data on drug industry expenditure to persuade legislators and government
Rev. Saúde Pública. Publicado em: 22/12/2016
-
4. Medicalización más allá de los médicos: marketing farmacéutico en torno al trastorno por déficit de atención e hiperactividad en Argentina y Brasil (1998-2014)
Abstract From a critical analysis of medicalization studies, and as a contribution to these perspectives, we describe and analyze the ways in which the transnational pharmaceutical industry penetrates diverse social spaces, with different marketing strategies, to consolidate medicalized processes in Argentina and Brazil. We analyzed two expansion methods of
Saude soc.. Publicado em: 2016-06
-
5. Desafios da indústria farmacêutica brasileira
The paper traces a panorama of the development of new drugs and hopes to contribute for Brazil to become a player in the discovery of new drugs. Brazil is the sixth world market retail consumer of medicines prone to expansion, has a pharmaceutical industry focused on the production of generics and a very large number of undergraduate courses in Pharmacy. The
Quím. Nova. Publicado em: 2013
-
6. A assistência farmacêutica no Brasil contemporâneo: a produção pública de medicamento permite ampliar o acesso da população ao uso racional de medicamentos? / Pharmaceutical assistance in the brazilian contemporary context: does pharmaceutical production by the State allow imporved access to rational medicine use by the population ?
O presente estudo avalia a produção pública de medicamentos no Brasil, abordando as possibilidades de avanços no acesso aos medicamentos essenciais. Fundamentou-se na análise bibliográfica e documental. Esta última análise focou os documentos oficiais, originários dos diversos agentes institucionais vinculados à política de medicamentos do país.
Publicado em: 2011
-
7. Fitoprodutos e desenvolvimento econômico
Natural products have been, historically, very important for Brazil. Coffee, sugar and soy were some examples that prove this economical significance. A project that involves phytoproducts should be guide by three main axis: agriculture management for the plants; pharmaceutical; support the national industry and academy. In Brazil, pharmaceutical products co
Química Nova. Publicado em: 2010
-
8. Estratégias tecnológicas em transformação: um estudo da indústria farmacêutica brasileira
The aim of this research is to examine the extension of changes on technological strategies of a group of Brazilian pharmaceutical companies, which we believe were induced by transformations in the institutional environment, occurred during the 1990s. We support that important institutional changes, as Patent‟s and Generic‟s Laws, have induced tr
Publicado em: 2010
-
9. Apoio governamental à inovação Tecnológica: análise da indústria farmacêutica paraense
As transformações econômicas, culturais e sociais que ocorrem em âmbito mundial estão associadas ao intenso avanço e expansão de novas tecnologias, forçando governos, pessoas, empresas e nações à introdução de novos padrões de comportamento, obrigando, desse modo, à renovação contínua de produtos e processos tecnológicos para manter a comp
Publicado em: 2010
-
10. A industria farmaceutica brasileira : um processo de co-evolução de instituições, organizações industriais, ciencia e tecnologia / The brazilian pharmaceutical industry : a co-evolution process between science, technology, institutuions and industrial organizations
This dissertation deals with a path-dependence analysis of the Brazilian pharmaceutical industry to show how the local firms are incorporating innovative activities, having elements of both Evolutionary and Institutional Economics as the theoretical background. By means of interviews with industry s players, the gathering of secondary source s information, a
Publicado em: 2009
-
11. Planning and control of projects in a center of bioequivalence / Planejamento e controle de projetos em um centro de bioequivalencia
At the same time globalization forces national markets to be more competitive, customers have more options of products and services, and therefore become more demand of improved quality and reduced prices. In the pharmaceutical industry as a consequence, bioequivalence centers have to adapt to this relatively new scenery to provide more qualified products wi
Publicado em: 2009
-
12. O processo decisório estratégico de estabelecimento de parcerias para aprendizagem interorganizacional na indústria farmacêutica do Estado de São Paulo
This thesis attempts to study and to examine the new ways of relationship based on interorganizational models in the pharmaceutical industry in the State of São Paulo. This segment is a privileged object of study for this purpose due to its needs of high investments in research and development, the dynamic nature of its environment, the complexity and the w
Publicado em: 2009